Last update 08 Dec 2024

Human Coagulation Factor IX (Yuanda Shuyang)

Overview

Basic Info

Drug Type
Non-recombinant coagulation factor
Synonyms
蜀阳茵玖
Target
factor IX
Mechanism
factor IX stimulants(Coagulation factor IX stimulants)
Therapeutic Areas
Congenital DisordersHemic and Lymphatic DiseasesOther Diseases
Active Indication
Hemophilia B
Inactive Indication
Hemorrhage
Originator Organization
Yuanda Shuyang Life Science (Chengdu) Co., Ltd.Yuanda Shuyang Life Science (Chengdu) Co., Ltd.
Active Organization
Yuanda Shuyang Life Science (Chengdu) Co., Ltd.Yuanda Shuyang Life Science (Chengdu) Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (14 Feb 2023),
Hemophilia B
RegulationPriority Review (CN)
Login to view timeline

Related

2
Clinical Trials associated with Human Coagulation Factor IX (Yuanda Shuyang)
CTR20241671 / RecruitingPhase 1
评价人凝血因子IX治疗中重型血友病B药代动力学特征的单臂、开放性、多中心临床研究
[Translation] A single-arm, open-label, multicenter clinical study to evaluate the pharmacokinetic characteristics of human coagulation factor IX in the treatment of moderate to severe hemophilia B
CTR20171073 / CompletedPhase 3
单臂、开放性、多中心临床试验评价人凝血因子IX治疗乙型血友病的有效性和安全性研究
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the efficacy and safety of human coagulation factor IX in the treatment of hemophilia B
100 Clinical Results associated with Human Coagulation Factor IX (Yuanda Shuyang)
Login to view more data
100 Translational Medicine associated with Human Coagulation Factor IX (Yuanda Shuyang)
Login to view more data
100 Patents (Medical) associated with Human Coagulation Factor IX (Yuanda Shuyang)
Login to view more data
100 Deals associated with Human Coagulation Factor IX (Yuanda Shuyang)
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemophilia B
CN
Yuanda Shuyang Life Science (Chengdu) Co., Ltd.Yuanda Shuyang Life Science (Chengdu) Co., Ltd.
14 Feb 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HemorrhagePhase 3
CN
Yuanda Shuyang Life Science (Chengdu) Co., Ltd.Yuanda Shuyang Life Science (Chengdu) Co., Ltd.
13 Nov 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free